Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $16.71 in the last session, up 1.70% from day before closing price of $16.43. In other words, the price has increased by $1.70 from its previous closing price. On the day, 2.27 million shares were traded. ADMA stock price reached its highest trading level at $16.751 during the session, while it also had its lowest trading level at $16.2.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.44. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Guiheen Lawrence P. sold 9,000 shares for $18.47 per share. The transaction valued at 166,189 led to the insider holds 153,941 shares of the business.
Guiheen Lawrence P. bought 9,000 shares of ADMA for $146,340 on Sep 09 ’24. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the COO and SVP, Compliance of the company, sold 24,150 shares for $16.90 each. As a result, the insider received 408,050 and left with 449,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 3894816768 and an Enterprise Value of 3947968000. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 118.85, and their Forward P/E ratio for the next fiscal year is 25.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.79 while its Price-to-Book (P/B) ratio in mrq is 20.68. Its current Enterprise Value per Revenue stands at 11.955 whereas that against EBITDA is 41.517.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $21.13, while it has fallen to a 52-week low of $3.23. The 50-Day Moving Average of the stock is -6.57%, while the 200-Day Moving Average is calculated to be 53.15%.
Shares Statistics:
According to the various share statistics, ADMA traded on average about 5.22M shares per day over the past 3-months and 2976190 shares per day over the past 10 days. A total of 226.06M shares are outstanding, with a floating share count of 225.20M. Insiders hold about 3.38% of the company’s shares, while institutions hold 80.08% stake in the company. Shares short for ADMA as of 1728950400 were 16073315 with a Short Ratio of 3.08, compared to 1726185600 on 12421213. Therefore, it implies a Short% of Shares Outstanding of 16073315 and a Short% of Float of 7.1.
